Terms: = Thyroid cancer AND MALAT1, PRO1073, 378938, Q9UHZ2
24 results:
1. Brain atlas for glycoprotein hormone receptors at single-transcript level.
Ryu V; Gumerova A; Korkmaz F; Kang SS; Katsel P; Miyashita S; Kannangara H; Cullen L; Chan P; Kuo T; Padilla A; Sultana F; Wizman SA; Kramskiy N; Zaidi S; Kim SM; New MI; Rosen CJ; Goosens KA; Frolinger T; Haroutunian V; Ye K; Lizneva D; Davies TF; Yuen T; Zaidi M
Elife; 2022 Sep; 11():. PubMed ID: 36052994
[TBL] [Abstract] [Full Text] [Related]
2. Long Non-Coding RNAs Profiling Using Microarray in Papillary thyroid Carcinoma.
Islam F; Zhou Y; Lam AK
Methods Mol Biol; 2022; 2534():135-148. PubMed ID: 35670973
[TBL] [Abstract] [Full Text] [Related]
3. Esophageal plexiform fibromyxoma: A case report with molecular analysis for malat1-GLI1 fusion.
Higashi M; Hamada T; Sasaki K; Tsuruda Y; Shimonosono M; Kitazono I; Kirishima M; Tasaki T; Noguchi H; Tabata K; Hisaoka M; Fukukura Y; Ohtsuka T; Tanimoto A
Pathol Res Pract; 2022 May; 233():153878. PubMed ID: 35397317
[TBL] [Abstract] [Full Text] [Related]
4. Programmable RNA N
Xie S; Jin H; Yang F; Zheng H; Chang Y; Liao Y; Zhang Y; Zhou T; Li Y
Angew Chem Int Ed Engl; 2021 Sep; 60(36):19592-19597. PubMed ID: 34081827
[TBL] [Abstract] [Full Text] [Related]
5. RMRP, RMST, FTX and IPW: novel potential long non-coding RNAs in medullary thyroid cancer.
Luzón-Toro B; Villalba-Benito L; Fernández RM; Torroglosa A; Antiñolo G; Borrego S
Orphanet J Rare Dis; 2021 Jan; 16(1):4. PubMed ID: 33407723
[TBL] [Abstract] [Full Text] [Related]
6. LncRNA malat1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p.
Yue X; Wu WY; Dong M; Guo M
Biomed J; 2021 Dec; 44(6 Suppl 2):S296-S304. PubMed ID: 35410813
[TBL] [Abstract] [Full Text] [Related]
7. Combined molecular and mathematical analysis of long noncoding RNAs expression in fine needle aspiration biopsies as novel tool for early diagnosis of thyroid cancer.
Possieri C; Locantore P; Salis C; Bacci L; Aiello A; Fadda G; De Crea C; Raffaelli M; Bellantone R; Grassi C; Strigari L; Farsetti A; Pontecorvi A; Nanni S
Endocrine; 2021 Jun; 72(3):711-720. PubMed ID: 33030666
[TBL] [Abstract] [Full Text] [Related]
8. [Long-chain non-coding RNA malat1 regulates paclitaxel resistance of breast cancer cells by targeting miR-485-3p].
Aini S; Yan H; Ding W; Adi L; Su P
Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):698-702. PubMed ID: 32897218
[TBL] [Abstract] [Full Text] [Related]
9. Suppression of Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (malat1) Potentiates Cell Apoptosis and Drug Sensitivity to Taxanes and Adriamycin in Breast cancer.
Yu J; Jin T; Zhang T
Med Sci Monit; 2020 Jul; 26():e922672. PubMed ID: 32623440
[TBL] [Abstract] [Full Text] [Related]
10. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
Peng Y; Fang X; Yao H; Zhang Y; Shi J
Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
[No Abstract] [Full Text] [Related]
11. m
Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
[TBL] [Abstract] [Full Text] [Related]
12. Long noncoding RNA malat1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract] [Full Text] [Related]
13. malat1 rs619586 polymorphism functions as a prognostic biomarker in the management of differentiated thyroid carcinoma.
Wang ML; Liu JX
J Cell Physiol; 2020 Feb; 235(2):1700-1710. PubMed ID: 31456244
[TBL] [Abstract] [Full Text] [Related]
14. Transcript-level regulation of malat1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
[TBL] [Abstract] [Full Text] [Related]
15. Long Non-Coding RNAs in thyroid cancer: Implications for Pathogenesis, Diagnosis, and Therapy.
Mahmoudian-Sani MR; Jalali A; Jamshidi M; Moridi H; Alghasi A; Shojaeian A; Mobini GR
Oncol Res Treat; 2019; 42(3):136-142. PubMed ID: 30799425
[TBL] [Abstract] [Full Text] [Related]
16. Upregulation of long noncoding RNA malat1 in papillary thyroid cancer and its diagnostic value.
Liu J; Dong H; Yang Y; Qian Y; Liu J; Li Z; Guan H; Chen Z; Li C; Zhang K; Zhang Q; Cao W; Lv J
Future Oncol; 2018 Dec; 14(29):3015-3022. PubMed ID: 29987950
[TBL] [Abstract] [Full Text] [Related]
17. thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs.
Hardin H; Helein H; Meyer K; Robertson S; Zhang R; Zhong W; Lloyd RV
Lab Invest; 2018 Sep; 98(9):1133-1142. PubMed ID: 29967342
[TBL] [Abstract] [Full Text] [Related]
18. MicroRNA-21 and long non-coding RNA malat1 are overexpressed markers in medullary thyroid carcinoma.
Chu YH; Hardin H; Schneider DF; Chen H; Lloyd RV
Exp Mol Pathol; 2017 Oct; 103(2):229-236. PubMed ID: 29107050
[TBL] [Abstract] [Full Text] [Related]
19. Long non-coding RNA malat1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
Zuo Y; Li Y; Zhou Z; Ma M; Fu K
Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
[TBL] [Abstract] [Full Text] [Related]
20. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell thyroid Neoplasm.
Covach A; Patel S; Hardin H; Lloyd RV
Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
[TBL] [Abstract] [Full Text] [Related]
[Next]
